High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury

Cancer Therapy–Related Cardiac Dysfunction and Heart Failure

(2016) Carine E. Hamo et al.   Circulation-Heart Failure

Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy

(2015) Lin Wang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

How acute changes in cardiac troponin concentrations help to handle the challenges posed by troponin elevations in non-ACS-patients

(2015) Karin Wildi et al.   CLINICAL BIOCHEMISTRY

Impact of Sex on the Prognostic Value of High-Sensitivity Cardiac Troponin I in the General Population: The HUNT Study

(2015) T. Omland et al.   CLINICAL CHEMISTRY

Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab

(2015) M. Putt et al.   CLINICAL CHEMISTRY

Insights into cardio-oncology: The patient's heavy cancer journey among doubts, controversies and pitfalls. The role of the cardiologist

(2015) Salvatore Patanè   INTERNATIONAL JOURNAL OF CARDIOLOGY

Use of Observed Within-Person Variation of Cardiac Troponin in Emergency Department Patients for Determination of Biological Variation and Percentage and Absolute Reference Change Values

(2014) A. J. Simpson et al.   CLINICAL CHEMISTRY

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent study

(2013) Catherine M McGorrian et al.   BMC Cardiovascular Disorders

Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy

(2013) Sinziana Seicean et al.   Circulation-Heart Failure

Evaluation of ultrasensitive cardiac Troponin I levels in patients with breast cancer during chemotherapy

(2013) Ricardo Moreno et al.   CLINICA CHIMICA ACTA

Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab

(2013) Bonnie Ky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

(2012) Heloisa Sawaya et al.   Circulation-Cardiovascular Imaging

Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population

(2012) F. S. Apple et al.   CLINICAL CHEMISTRY

Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy

(2012) Sinziana Seicean et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients

(2011) Heloisa Sawaya et al.   AMERICAN JOURNAL OF CARDIOLOGY

Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine?

(2011) F. S. Apple et al.   CLINICAL CHEMISTRY

Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays

(2011) F. S. Apple et al.   CLINICAL CHEMISTRY

Pathobiology of Troponin Elevations⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

(2011) Harvey D. White   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

(2010) Daniela Cardinale et al.   JOURNAL OF CLINICAL ONCOLOGY